Caplin Point Laboratories Completes Transformation with Focus on AI and Nutraceuticals

Caplin Point Laboratories has undergone a significant transformation over the past decade, shifting from manufacturing pure generics to bio generics, and from smaller markets to larger markets. The company has also started using Artificial Intelligence (AI) to enhance operations and create nutraceuticals and dietary supplements. This transformation has been driven by the company's commitment to its belief and value system, ensuring that every change is in the right direction. The annual report contains forward-looking statements that set out anticipated results based on management's plans and assumptions, but actual results could vary materially due to risks, uncertainties, or inaccurate assumptions.